Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cartesian Therapeutics (RNAC) Intangibles: 2023-2024

Historic Intangibles for Cartesian Therapeutics (RNAC) over the last 2 years, with Dec 2024 value amounting to $150.6 million.

  • Cartesian Therapeutics' Intangibles changed negligibly% to $150.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $150.6 million, marking a year-over-year negligible change of negligibly%. This contributed to the annual value of $150.6 million for FY2024, which is negligibly% changed negligibly from last year.
  • According to the latest figures from FY2024, Cartesian Therapeutics' Intangibles is $150.6 million, which was down 0.00% from $150.6 million recorded in FY2023.
  • Cartesian Therapeutics' Intangibles' 5-year high stood at $150.6 million during FY2023, with a 5-year trough of $150.6 million in FY2023.
  • In the last 2 years, Cartesian Therapeutics' Intangibles had a median value of $150.6 million in 2024 and averaged $150.6 million.